• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    Esophageal Dysphagia Market Research Report – Forecast to 2032 Infographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Esophageal Dysphagia Market

    ID: MRFR/MED/5002-HCR
    90 Pages
    Rahul Gotadki
    September 2025

    Esophageal Dysphagia Market Research Report Information By Diagnosis (Dynamic Swallowing Study, X-ray, Endoscopy, Manometry, Imaging scans, MRI scan, and CT scan), By Treatment (Esophageal Dilation, Surgery, Stent Placement, Laparoscopic Heller Myotomy, Medications, and Lifestyle Changes), By Products (Feeding Tube, Nasogastric Tube, Percutaneous Endoscopic Gastrostomy, Nutritional Solutions, Thickeners, Beverages, Purees, Drugs, Proton Pump Inhibitors, and Other), & End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Diagnosti...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Esophageal Dysphagia Market Research Report – Forecast to 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    Esophageal Dysphagia Market Summary

    As per Market Research Future Analysis, the Global Esophageal Dysphagia Market was valued at USD 1.91 Billion in 2023 and is projected to reach USD 3.09 Billion by 2032, growing at a CAGR of 5.40% from 2024 to 2032. Key drivers include an aging population, rising cancer rates, and increased healthcare spending. The market is also influenced by lifestyle factors such as smoking and sedentary behavior, which contribute to the prevalence of dysphagia. The endoscopy segment leads the diagnosis market, while esophageal dilation dominates treatment. North America holds the largest market share, driven by high healthcare expenditure and a significant aging demographic.

    Key Market Trends & Highlights

    The esophageal dysphagia market is witnessing significant growth due to various factors.

    • Market Size in 2023: USD 1.91 Billion; projected to reach USD 3.09 Billion by 2032.
    • CAGR of 5.40% during the forecast period (2024 - 2032).
    • Endoscopy segment accounted for 37.5% of market revenue in 2022.
    • North America is the largest market, driven by a high prevalence of gastrointestinal disorders.

    Market Size & Forecast

    2023 Market Size USD 1.91 Billion
    2024 Market Size USD 2.02 Billion
    2032 Market Size USD 3.09 Billion
    CAGR 5.40%

    Major Players

    Key players include Nestlé Health Science France, AstraZeneca Plc, Cook Medical Incorporated, Cipla Ltd, and Merck Sharp & Dohme Corp.

    Esophageal Dysphagia Market Trends

      • Growing number of smokers is driving the market growth

    Market CAGR for esophageal dysphagia is driven by the rising number of smokers. The growing number of smokers is expected to impact the market's expansion during the projected time. Dysphagia is one of the most severe side effects of long-term cigarette smoking.  For instance, the World Health Organisation (WHO), a  public health organization headquartered in Switzerland, estimates that by May 2022, tobacco will be a factor in more than 8 million deaths annually.

    More than 7 million fatalities are due to direct tobacco use, whereas around 1.2 million are from non-smokers exposed to secondhand smoke.  While smoking causes the deaths of almost 6 million people annually, the market for esophageal dysphagia is steadily growing because of the increasing incidence of oropharyngeal cancer.

    The primary factor influencing the growth rate of the esophageal dysphagia market is the rise in healthcare spending, which aids in constructing its infrastructure. The market for esophageal dysphagia will expand due to increased awareness-raising efforts by public and private organizations. the rising need for dysphagia management in healthcare services and medical institutions, and the increase in disposable money. One of the major elements driving the  market is the growing number of smokers who will develop addictions throughout the forecast period. The rising prevalence of dysphagia, particularly among older people, drives the demand for esophageal dysphagia.

    The market is expanding because of the development of cutting-edge dysphagia management techniques such as video fluoroscopy systems, neuromuscular electrical stimulation devices, and fiberoptic endoscopic evaluation of swallowing (FEES) systems. Thus, driving the esophageal dysphagia market revenue.

    The increasing prevalence of esophageal dysphagia among aging populations suggests a growing need for innovative therapeutic solutions and enhanced patient management strategies.

    U.S. National Institutes of Health (NIH)

    Esophageal Dysphagia Market Drivers

    Market Growth Chart

    Emerging Treatment Options

    The Global Esophageal Dysphagia Market Industry is witnessing a surge in emerging treatment options, including pharmacological therapies and minimally invasive surgical procedures. Innovations in drug development are leading to the introduction of new medications that target the underlying causes of dysphagia, while advancements in surgical techniques are providing patients with safer and more effective solutions. This diversification of treatment modalities is likely to attract a broader patient base, thereby expanding the market. As the industry evolves, the integration of these new options is expected to enhance patient outcomes and satisfaction.

    Growing Geriatric Population

    The aging population is a crucial driver of the Global Esophageal Dysphagia Market Industry. As individuals age, the risk of developing dysphagia increases due to age-related physiological changes and comorbidities. Reports suggest that approximately 30 to 40 percent of elderly individuals experience swallowing difficulties, which can lead to malnutrition and aspiration pneumonia. This demographic shift is expected to contribute to the market's expansion, with projections indicating a market value of 3.62 USD Billion by 2035. The increasing need for specialized care and tailored treatment options for the elderly population will likely stimulate demand within the industry.

    Increased Awareness and Education

    Rising awareness and education regarding esophageal dysphagia are pivotal in shaping the Global Esophageal Dysphagia Market Industry. Healthcare campaigns aimed at educating both patients and providers about the symptoms and consequences of dysphagia are becoming more prevalent. This heightened awareness encourages individuals to seek medical advice sooner, leading to earlier diagnosis and treatment. Consequently, the market is expected to benefit from this trend, as more patients are identified and treated for dysphagia. The emphasis on patient education may also drive the development of new therapies and interventions, further enhancing market growth.

    Advancements in Diagnostic Technologies

    Technological advancements in diagnostic tools are significantly influencing the Global Esophageal Dysphagia Market Industry. Innovations such as high-resolution manometry and endoscopic ultrasound have improved the accuracy of diagnosing dysphagia. These technologies enable healthcare professionals to identify underlying causes more effectively, leading to timely interventions. As a result, the market is poised for growth, with an anticipated compound annual growth rate (CAGR) of 5.44% from 2025 to 2035. Enhanced diagnostic capabilities not only facilitate better patient outcomes but also encourage healthcare providers to adopt new treatment modalities, thereby expanding the market.

    Rising Prevalence of Esophageal Disorders

    The Global Esophageal Dysphagia Market Industry is experiencing growth due to the increasing prevalence of esophageal disorders. Conditions such as gastroesophageal reflux disease (GERD) and esophageal cancer are becoming more common, leading to a higher incidence of dysphagia. For instance, studies indicate that approximately 15 to 20 percent of adults experience GERD, which can lead to swallowing difficulties. This trend is expected to drive the market, with projections estimating the market value to reach 2.02 USD Billion in 2024. As awareness of these conditions grows, the demand for effective treatment options is likely to rise, further propelling the market forward.

    Market Segment Insights

    Esophageal Dysphagia Diagnosis Insights

    The  esophageal dysphagia market segmentation, based on diagnosis, includes dynamic swallowing study, x-ray, endoscopy, manometry, imaging scans, MRI scan, and CT scan. The endoscopy segment dominated the market, accounting for 37.5% of market revenue (78.48 Billion). Endoscopy equipment's less intrusive features, and reasonable post- and pre-procedure costs are the main elements projected to boost sector expansion throughout the projection period. The  sector for manometry systems is projected to be driven by rising per capita healthcare spending and increased investment in the construction of healthcare infrastructure.

    Figure 1  Esophageal Dysphagia Market, by Diagnosis, 2022 & 2032 (USD Billion)

    Source Secondary Research, Primary Research, MRFR Database and Analyst Review

    Esophageal Dysphagia Treatment Insights

    The  esophageal dysphagia market segmentation, based on treatment, includes esophageal dilation, surgery, stent placement, laparoscopic heller myotomy, medications, and lifestyle changes. Esophageal dilation segment dominated the market in the forecast period. High demand for minimally invasive procedures, rising prevalence of esophageal cancer, malignant & benign illnesses, rising number of surgical operations, and technical advancements in R&D activities are the key factors driving the growth of the esophageal stents segment. Furthermore, surgical treatment saw considerable growth in market share.

    The need for endoscopic surgery is anticipated to increase due to the increasing prevalence of target diseases like cancer, which will fuel this market's expansion in the future.

    Esophageal Dysphagia Product Insights

    The  esophageal dysphagia market segmentation, based on product, includes feeding tubes, nasogastric tubes, percutaneous endoscopic gastrostomy, nutritional solutions, thickeners, beverages, purees, drugs, proton pump inhibitors, and others. In 2022, the feeding tubes segment dominated the market. These developments have accelerated the market expansion for feeding tubes. Feeding tubes now have cutting-edge features, such as pressure alarm settings and pre-set cleansing intervals.

    March 2021, Applied Medical Technology, Inc. (US) expanded its gastric-jejunal enteral feeding tube family (G-JETS) to include the low-profile micro-G-JET to fulfill the enteral nutrition demands of pediatric patients. The tiny G-JET alternates between a 14F gastric segment and an 8F jejunal segment.

    Additionally, in 2022, the proton pump inhibitors segment witnessed the fastest growth rate. The rising incidence of gastroesophageal reflux disease (GERD) and the growing acceptance of novel medicine delivery systems are the two key factors influencing the sector's growth.

    Esophageal Dysphagia End-User Insights

    The  esophageal dysphagia market segmentation, based on end-user, includes hospitals and clinics, ambulatory surgical centers, diagnostic centers, research centers, and others. In 2022, the hospitals segment dominated the market. The key factor driving the hospital segment is the rising prevalence of gastrointestinal and ingestion problems among the aging population.  Additionally, it is predicted that the category of ambulatory surgery centers/clinics will experience the highest CAGR throughout the forecast years. Some key factors anticipated to propel the segment's expansion include the increasing desire for minimally invasive procedures to lower total costs and reduce the number of hospital days.

    Get more detailed insights about Esophageal Dysphagia Market Research Report – Forecast to 2032

    Request Free Sample

    Regional Insights

    By region, the study provides market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American esophageal dysphagia market area will dominate this market. The rising prevalence of gastrointestinal illnesses, favorable reimbursement practices, an aging population, and the presence of sizable market participants are the primary drivers of the enormous market size in North America. According to an article, GERD affects 18.1% to 27.8% of individuals annually in the United States, making it the most common digestive disorder.

    Further, the major countries studied in the market report are US, Canada, France, German, Italy, UK, Spain, Japan, China, Australia, India, South Korea, and Brazil.

    Figure 2  ESOPHAGEAL DYSPHAGIA MARKET SHARE BY REGION 2022 (USD Billion)ESOPHAGEAL DYSPHAGIA MARKET SHARE BY REGION 2022

    Source Secondary Research, Primary Research, MRFR Database and Analyst Review

    Europe’s esophageal dysphagia market accounts for the second-largest market share. The acceptance of endoscopic operations in this area is driven by the growing senior population and those predisposed to many chronic illnesses. One of the key elements further encouraging market expansion in the region is the increasing government measures to modernize healthcare facilities. Further, the German esophageal dysphagia market held the largest market share, and the UK esophageal dysphagia market was the rapidly growing market in the European region.

    The Asia-Pacific Esophageal Dysphagia Market is expected to grow at the fastest CAGR from 2024 to 2032. The area has a sizable unmet need for facilities to treat digestive illnesses, and patient awareness of these facilities is growing, particularly in developing countries like India, China, and Indonesia. As a result, product demand is anticipated to rise throughout the forecasted period. Moreover, China’s esophageal dysphagia market held the largest market share, and the Indian esophageal dysphagia market was the rapidly growing market in the Asia-Pacific region.

    Key Players and Competitive Insights

    Leading market players are largely investing in research and development to expand their product lines, which will help the esophageal dysphagia market, grow even more. The launch of new products, larger-scale mergers and acquisitions, contractual agreements, and collaboration with other organizations are significant market developments in which market participants engage to increase their  presence. The esophageal dysphagia industry must provide affordable products to expand and thrive in a more competitive and challenging market environment.

    One of the major business strategies manufacturers use in the  esophageal dysphagia industry to increase market sector and benefit customers is local manufacturing to lower operational costs. In recent years, the esophageal dysphagia industry has stipulated some of the most important medicinal benefits.  Major players in the esophageal dysphagia industry, including Nestlé Health Science France, AstraZeneca Plc, Cook Medical Incorporated, Cipla Ltd, Merck Sharp & Dohme Corp, and others, are funding operations for research and development to boost market demand.

    Since 1987, Thick-It quick food thickening products have changed how people think about food and dysphagia care. Their mission has been to develop safe products that optimize the daily lives of people who have suffered from dysphagia and have provided treatment to them for over twenty years. They will continue to devote themselves to developing and upgrading products that address the ever-changing needs of people with difficulty swallowing and their carers. In September 2020, Thick-It Brand announced the release of a dysphagia nutrition variety pack. The new packs include Purée Protein, Purée Vegetable, and Ready-to-Drink.

    The ready-to-drink options come in IDDSI Level 2 - Mildly Thick (nectar) and IDDSI Level 3 - Moderately Thick (honey) consistencies.

    Nestlé India Limited is Nestlé's Indian affiliate. Nestlé is a Swiss  corporation. The company's main office is in Gurgaon, Haryana. The products that the corporation sells include food, drinks, chocolate, and confections. Nestle, Nescafe, Perrier, Pure Life, and Purina are among its extensive product portfolio brands. In January 2023, Nestlé India introduced ThickenUp Clear, a food and beverage thickening that can aid patients suffering from swallowing difficulties, particularly oropharyngeal dysphagia. It can be given to people with difficulty swallowing due to illnesses including head and neck cancer, stroke, or Parkinson's disease, among others.

    Dysphagia is a serious but underappreciated health problem that causes dehydration, malnutrition-related illnesses, and a lower quality of life.

    Key Companies in the Esophageal Dysphagia Market market include

    Industry Developments

    In January 2023, TWi Pharmaceuticals, Inc. ("TWi") announced today the formal introduction of an Authorised Generic of Takeda's Dexilant® (Dexlansoprazole) Delayed-Release Capsules through its wholly owned US subsidiary, TWi Pharmaceuticals USA, Inc. The product is ready for quick dispatch. Dexlansprazole DR Capsules treat heartburn caused by gastroesophageal reflux disease (GERD) and mend erosive esophagitis (esophageal damage caused by stomach acid).

    In April 2022, Daewon Pharmaceutical introduced Escorten, one of Korea's earliest proton-pump inhibitor medications. It is a 10mg esomeprazole magnesium trihydrate tablet. The company began developing the medicine in 2019, completed phase 1 clinical trials in the first half of 2020, and demonstrated its efficacy in treating gastritis in large-scale phase 3 clinical trials involving 27 general hospitals.

    Future Outlook

    Esophageal Dysphagia Market Future Outlook

    The Esophageal Dysphagia Market is projected to grow at a 5.44% CAGR from 2024 to 2035, driven by rising prevalence, technological advancements, and increased awareness.

    New opportunities lie in:

    • Develop innovative therapeutic solutions targeting specific patient demographics.
    • Leverage telehealth platforms for remote diagnosis and management of dysphagia.
    • Invest in educational programs to enhance awareness among healthcare professionals.

    By 2035, the Esophageal Dysphagia Market is expected to exhibit robust growth, reflecting evolving healthcare needs.

    Market Segmentation

    Esophageal Dysphagia Product Outlook

    • Feeding Tube
    • Nasogastric Tube
    • Percutaneous Endoscopic Gastrostomy
    • Nutritional Solutions
    • Thickeners
    • Beverages
    • Purees
    • Drugs
    • Proton Pump Inhibitors
    • Other

    Esophageal Dysphagia End-User Outlook

    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Research Centers
    • Others

    Esophageal Dysphagia Regional Outlook

    • US
    • Canada

    Esophageal Dysphagia Diagnosis Outlook

    • Dynamic Swallowing Study
    • X-ray
    • Endoscope
    • Manometry
    • Imaging scans
    • MRI scan
    • CT scan

    Esophageal Dysphagia Treatment Outlook

    • Esophageal Dilation
    • Surgery
    • Stent placement
    • Laparoscopic Heller Myotomy
    • Medications
    • Lifestyle Changes

    Report Scope

    Esophageal Dysphagia Report Scope
    Report Attribute/Metric Details
    Market Size 2023 USD 1.91 Billion
    Market Size 2024 USD 2.02 Billion
    Market Size 2032 USD 3.09 Billion
    Compound Annual Growth Rate (CAGR) 5.40% (2024-2032)
    Base Year 2023
    Market Forecast Period 2024-2032
    Historical Data 2018- 2022
    Market Forecast Units Value (USD Billion)
    Report Coverage Market Competitive Landscape, Growth Factors, Revenue Forecast, and Trends
    Segments Covered Diagnosis, Treatment, Product, and End-User
    Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
    Countries Covered US, Canada, France, German, Italy, UK, Spain, Japan, China, Australia, India, South Korea, and Brazil.
    Key Companies Profiled Nestlé Health Science France, AstraZeneca Plc, Cook Medical Incorporated, Cipla Ltd, and Merck Sharp & Dohme Corp
    Key Market Opportunities High growth opportunities for market players in developing countries
    Key Market Dynamics Increasing Prevalence of Esophageal Chronic Disorders

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    How much is the esophageal dysphagia market?

    The  market size of the esophageal dysphagia market was prized at USD 1.91 Billion in 2023.

    What is the growth rate of the esophageal dysphagia market?

    From 2024 to 2032, the anticipated CAGR for the  market is 5.40%.

    Which region held the major market share in the esophageal dysphagia market?

    The major portion of the  market was accounted for by North America.

    Who are the notable players in the esophageal dysphagia market?

    The notable players in the market are Nestlé Health Science France, AstraZeneca Plc, Cook Medical Incorporated, Cipla Ltd, and Merck Sharp & Dohme Corp.

    Which treatment led to the esophageal dysphagia market?

    The esophageal stent placement treatment dominated the market in 2023.

    Which product had the major market share in the esophageal dysphagia market?

    The feeding tube sector had the largest share of the market.

    1. 'TABLE OF CONTENT    
    2. Chapter 1.    Report
    3. Prologue    
    4. Chapter 2.    Market Introduction  
      1.     Definition    
    5.  Scope of the Study    
      1.     Research
    6. Objective    
      1.     Assumptions  
        1.     Limitations    
    7. Chapter
    8.     Research Methodology
      1.     Introduction
      2.     Primary Research    
    9.  Secondary Research    
      1.     Market Size
    10. Estimation
    11. Chapter 4.    Market Dynamics
    12.  Drivers    
      1.     Restraints
    13.  Opportunities    
      1.     Challenges
      2.     Macroeconomic Indicators
      3.     Technology
    14. Trends & Assessment            
    15. Chapter 5.    Market Factor Analysis
      1.     Porter’s
    16. Five Forces Analysis
      1.     Bargaining Power of Suppliers  
        1.     Bargaining Power of Buyers
    17.  Threat of New Entrants    
      1.     Threat
    18. of Substitutes    
      1.     Intensity of Rivalry  
      2.     Value Chain Analysis
      3.     Investment
    19. Feasibility Analysis    
      1.     Pricing Analysis
    20. Chapter 6.    Global Esophageal Dysphagia Market, by Diagnosis
      1.     Introduction
      2.      X-ray 
      3.     Dynamic swallowing study
      4.     Endoscopy
      5.     Manometry
      6.     Imaging scans
    21.  MRI scan
      1.     CT scan
    22. Chapter 7.  
    23.  Global Esophageal Dysphagia Market, by Treatment
      1.     Introduction
      2.     Esophageal dilation
      3.     Surgery
    24.           7.3.1    Stent placement
      1.     Laparoscopic Heller myotomy
      2.     Medications
      3.     Lifestyle changes
    25. Chapter 8.    Global
    26. Esophageal Dysphagia Market, by Products 
      1.     Introduction
      2.     Feeding Tube 
        1.     Nasogastric
    27. Tube
      1.     Percutaneous Endoscopic Gastrostomy
    28.   Nutritional Solutions
      1.     Thickeners
    29.  Beverages
      1.     Purees
      2.     Drugs
        1.     Proton Pump Inhibitors
      3.     Others
    30. Chapter 9.    Global Esophageal Dysphagia Market, by End-Users 
      1.     Introduction
      2.     Hospitals and clinics 
      3.     Ambulatory Surgical Centers
      4.     Diagnostic
    31. Centers
      1.     Research centers
      2.     Other
    32. Chapter 10.    Global Esophageal Dysphagia Market, by Region
    33.  10.1    Introduction
    34.  10.2    America
      1.     North America
        1.     US
    35.  Canada
      1.     South America
    36.  Europe
    37.  10.3.1    Western Europe
    38.  Germany
    39.  10.3.1.2    France
    40.  Italy
    41.  10.3.1.4    Spain
    42.  UK
    43.  10.3.1.6    Rest of Western Europe
    44.  Eastern Europe
    45.  10.4    Asia-Pacific
    46.  Japan
    47.  10.4.2    China
    48.  India
    49.  10.4.4    Australia
    50.  Republic of Korea
    51.  10.4.6    Rest of Asia-Pacific
    52.  10.5    Middle East & Africa 
    53.  United Arab Emirates
    54.  10.5.2    Saudi Arabia
    55.  Oman
    56.  10.5.4    Kuwait
    57.  Qatar
    58.  10.5.6    Rest of the Middle East & Africa 
    59. Chapter 11.    Company Landscape    
    60.  Introduction    
      1.     Market Share Analysis  
      2.     Key Development & Strategies  
        1.     Key Developments    
    61. Chapter
    62.     Company Profiles    
    63.  Merck Sharp & Dohme Corp   
    64.  12.1.1    Company
    65. Overview    
    66.  12.1.2    Type Overview  
    67.  12.1.3    Financials
    68.  Key Developments    
    69.  12.1.5    SWOT
    70. Analysis    
    71.  12.2    Biostagel  
    72.  12.2.1    Company Overview    
    73.  Type Overview    
    74.  12.2.3    Financial
    75. Overview    
    76.  12.2.4    Key Developments  
    77.  12.2.5    SWOT Analysis    
    78.  Torax Medical Inc.   
    79.  12.3.1    Company
    80. Overview    
    81.  12.3.2    Type Overview  
    82.  12.3.3    Financial Overview
    83.  Key Development    
    84.  12.3.5    SWOT
    85. Analysis    
    86.  12.4    Nine Point Medical
    87. Inc.  
    88.  12.4.1    Company Overview    
    89.  12.4.2    Type/Business Segment Overview    
    90.  12.4.3    Financial Overview    
    91.  Key Development    
    92.  12.4.5    SWOT
    93. Analysis    
    94.  12.5    Elekta AB
    95.  Company Overview    
    96.  12.5.2    Type
    97. Overview    
    98.  12.5.3    Financial overview  
    99.  12.5.4    Key Developments    
    100.  12.5.5    SWOT Analysis    
    101.  Eisai Co Ltd  
    102.  12.6.1    Company Overview  
    103.  12.6.2    Type Overview    
    104.  Financial Overview    
    105.  12.6.4    Key
    106. Developments    
    107.  12.6.5    SWOT Analysis  
    108.  12.7    Cipla Ltd.  
    109.  Overview    
    110.  12.7.2    Type Overview  
    111.  12.7.3    Financials    
    112.  Key Developments    
    113.  12.7.5    SWOT
    114. Analysis    
    115.      12.8    ASTRAZENECA
    116. PLC 
    117.  12.8.1    Overview    
    118.  Type Overview    
    119.  12.8.3    Financials  
    120.  12.8.4    Key Developments    
    121.  12.8.5    SWOT Analysis    
    122.   Kent Precision Foods Group, Inc
    123.  12.9.1    Overview  
    124.  12.9.2    Type Overview    
    125.  Financials    
    126.  12.9.4    Key Developments  
    127.  12.9.5    SWOT Analysis
    128.   Nestlé Health Science France
    129.  12.10.1 Overview  
    130.  12.10.2 Type Overview    
    131.  12.10.3 Financials  
    132.  12.10.4 Key Developments    
    133. SWOT Analysis
      1.      Nutricia Ltd
    134.  12.11.1 Overview  
    135.  12.11.2 Type Overview    
    136.  12.11.3 Financials  
    137.  12.11.4 Key Developments    
    138. SWOT Analysis
      1.      C.R. Bard, Inc.
    139.  12.12.1 Overview  
    140.  12.12.2 Type Overview    
    141.  12.12.3 Financials  
    142.  12.12.4 Key Developments    
    143. SWOT Analysis
      1.      Cook Medical Incorporated
    144. Overview    
    145.  12.13.2 Type Overview    
    146.  12.13.3 Financials    
    147.  12.13.4 Key Developments  
    148.  12.13.5 SWOT Analysis
    149.  12.14    Others
    150. Chapter 13     Appendix
    151.      Global Esophageal Dysphagia Market Industry Synopsis, 2023-2030
    152. Estimates & Forecast, 2023-2030, (USD Million)
    153.  Global Esophageal Dysphagia Market, by Region, 2023-2030, (USD Million)
    154. by Diagnosis, 2023-2030, (USD Million)
    155.  Global Esophageal Dysphagia Market, by Treatment, 2023-2030, (USD Million)
    156. by Product, 2023-2030, (USD Million)
    157.  Global Esophageal Dysphagia Market, by End-User, 2023-2030, (USD Million)
    158. Market, by Diagnosis, 2023-2030, (USD Million)
    159.  North America: Esophageal Dysphagia Market, by Treatment, 2023-2030, (USD
    160. Million)
    161. by   Product, 2023-2030, (USD Million)
    162. America: Esophageal Dysphagia Market, by End-User, 2023-2030, (USD Million)
    163.     US: Esophageal Dysphagia Market, by Diagnosis, 2023-2030, (USD
    164. Million)
    165. 2030, (USD Million)
    166. Market, by   Product, 2023-2030, (USD Million)
    167. Esophageal Dysphagia Market, by End-User, 2023-2030, (USD Million)
    168.  Canada: Esophageal Dysphagia Market, by Diagnosis, 2023-2030, (USD Million)
    169. 2030, (USD Million)
    170. Market, by   Product, 2023-2030, (USD Million)
    171. Esophageal Dysphagia Market, by End-User, 2023-2030, (USD Million)
    172.  South America: Esophageal Dysphagia Market, by Diagnosis, 2023-2030, (USD
    173. Million)
    174. by Treatment, 2023-2030, (USD Million)
    175. Esophageal Dysphagia Market, by   Product, 2023-2030, (USD Million)
    176.     South America: Esophageal Dysphagia Market, by End-User, 2023-2030,
    177. (USD Million)
    178. Diagnosis, 2023-2030, (USD Million)
    179. Dysphagia Market, by Treatment, 2023-2030, (USD Million)
    180.  Europe: Esophageal Dysphagia Market, by   Product, 2023-2030, (USD Million)
    181. (USD Million)
    182. Market, by Diagnosis, 2023-2030, (USD Million)
    183. Europe: Esophageal Dysphagia Market, by Treatment, 2023-2030, (USD Million)
    184.     Western Europe: Esophageal Dysphagia Market, by   Product,
    185. 2030, (USD Million)
    186. Dysphagia Market, by End-User, 2023-2030, (USD Million)
    187.  Eastern Europe: Esophageal Dysphagia Market, by Diagnosis, 2023-2030, (USD
    188. Million)
    189. by Treatment, 2023-2030, (USD Million)
    190. Esophageal Dysphagia Market, by End-User, 2023-2030, (USD Million)
    191.  Asia-Pacific: Esophageal Dysphagia Market, by Diagnosis, 2023-2030, (USD Million)
    192. 2030, (USD Million)
    193. Dysphagia Market, by   Product, 2023-2030, (USD Million)
    194.  Asia-Pacific: Esophageal Dysphagia Market, by End-User, 2023-2030, (USD Million)
    195. by Diagnosis, 2023-2030, (USD Million)
    196. & Africa: Esophageal Dysphagia Market, by Treatment, 2023-2030, (USD Million)
    197. by   Product, 2023-2030, (USD Million)
    198. East & Africa: Esophageal Dysphagia Market, by End-User, 2023-2030, (USD Million)
    199.     Segmentation for the Global Esophageal Dysphagia Market 
    200. Market 
    201. Share, by diagnosis 2023
    202. Market Share, by treatment, 2023
    203. Dysphagia Market Share, by product, 2023
    204. Esophageal Dysphagia Market Share, by End-User, 2023
    205. Esophageal Dysphagia Market Share, by Region, 2023
    206. America Esophageal Dysphagia Market Share, by Country, 2023
    207.  Europe Prescribed Health Apps Share, by Country, 2023
    208.  Asia-Pacific Esophageal Dysphagia Market Share, by Country, 2023
    209.     Middle East & Africa Esophageal Dysphagia Market Share,
    210. by Country, 2023
    211. Company Share Analysis, 2023 (%)
    212. Dohme Corp: Key Financials
    213. Corp: Segmental Revenue
    214. Corp: Geographical Revenue
    215.  Biostagel: Geographical Revenue
    216. Inc.: Key Financials
    217. Revenue
    218.     Nine Point Medical Inc.: Segmental Revenue
    219.  Nine Point Medical Inc.: Geographical Revenue
    220. Co Ltd: Key Financials
    221. Revenue
    222.     Cipla Ltd.: Key Financials
    223. Ltd.: Segmental Revenue
    224. Revenue
    225.     AstraZeneca Plc: Segmental Revenue
    226.  AstraZeneca Plc: Geographical Revenue
    227. Precision Foods Group, Inc: Key Financials
    228. Precision Foods Group, Inc: Segmental Revenue
    229. Precision Foods Group, Inc: Geographical Revenue
    230. Health Science France: Key Financials
    231. Health Science France: Segmental Revenue
    232. Health Science France: Geographical Revenue
    233. Ltd: Key Financials
    234.   C.R.Bard, Inc.: Key Financials
    235. Inc.: Segmental Revenue
    236. Revenue
    237.      Cook Medical Incorporated.: Geographical Revenue'

    Esophageal Dysphagia Market Segmentation

    Esophageal Dysphagia Diagnosis Outlook (USD Billion, 2018-2032)

    • Dynamic Swallowing Study
    • X-ray
    • Endoscope
    • Manometry
    • Imaging scans
    • MRI scan
    • CT scan

    Esophageal Dysphagia Treatment Outlook (USD Billion, 2018-2032)

    • Esophageal Dilation
    • Surgery
    • Stent placement
    • Laparoscopic Heller Myotomy
    • Medications
    • Lifestyle Changes

    Esophageal Dysphagia Product Outlook (USD Billion, 2018-2032)

    • Feeding Tube
    • Nasogastric Tube
    • Percutaneous Endoscopic Gastrostomy
    • Nutritional Solutions
    • Thickeners
    • Beverages
    • Purees
    • Drugs
    • Proton Pump Inhibitors
    • Other

    Esophageal Dysphagia End-User Outlook (USD Billion, 2018-2032)

    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Research Centers
    • Others

    Esophageal Dysphagia Regional Outlook (USD Billion, 2018-2032)

    • North America Outlook (USD Billion, 2018-2032)

    • North America Esophageal Dysphagia by Diagnosis

    • Dynamic Swallowing Study
    • X-ray
    • Endoscope
    • Manometry
    • Imaging scans
    • MRI scan
    • CT scan

    • North America Esophageal Dysphagia by Treatment

    • Esophageal Dilation
    • Surgery
    • Stent placement
    • Laparoscopic Heller Myotomy
    • Medications
    • Lifestyle Changes

    • North America Esophageal Dysphagia by Product

    • Feeding Tube
    • Nasogastric Tube
    • Percutaneous Endoscopic Gastrostomy
    • Nutritional Solutions
    • Thickeners
    • Beverages
    • Purees
    • Drugs
    • Proton Pump Inhibitors
    • Other

    • North America Esophageal Dysphagia by End-User

    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers

    • Research Centers

        • Others

      • US Outlook (USD Billion, 2018-2032)

    • US Esophageal Dysphagia by Diagnosis

    • Dynamic Swallowing Study
    • X-ray
    • Endoscope
    • Manometry
    • Imaging scans
    • MRI scan
    • CT scan

    • US Esophageal Dysphagia by Treatment

    • Esophageal Dilation
    • Surgery
    • Stent placement
    • Laparoscopic Heller Myotomy
    • Medications
    • Lifestyle Changes

    • US Esophageal Dysphagia by Product

    • Feeding Tube
    • Nasogastric Tube
    • Percutaneous Endoscopic Gastrostomy
    • Nutritional Solutions
    • Thickeners
    • Beverages
    • Purees
    • Drugs
    • Proton Pump Inhibitors
    • Other

    • US Esophageal Dysphagia by End-User

    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Research Centers
        • Others

      • CANADA Outlook (USD Billion, 2018-2032)

    • CANADA Esophageal Dysphagia by Diagnosis

    • Dynamic Swallowing Study
    • X-ray
    • Endoscope
    • Manometry
    • Imaging scans
    • MRI scan
    • CT scan

    • CANADA Esophageal Dysphagia by Treatment

    • Esophageal Dilation
    • Surgery
    • Stent placement
    • Laparoscopic Heller Myotomy
    • Medications
    • Lifestyle Changes

    • CANADA Esophageal Dysphagia by Product

    • Feeding Tube
    • Nasogastric Tube
    • Percutaneous Endoscopic Gastrostomy
    • Nutritional Solutions
    • Thickeners
    • Beverages
    • Purees
    • Drugs
    • Proton Pump Inhibitors
    • Other

    • CANADA Esophageal Dysphagia by End-User

    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Research Centers
        • Others

    • Europe Outlook (USD Billion, 2018-2032)

    • Europe Esophageal Dysphagia by Diagnosis

    • Dynamic Swallowing Study
    • X-ray
    • Endoscope
    • Manometry
    • Imaging scans
    • MRI scan
    • CT scan

    • Europe Esophageal Dysphagia by Treatment

    • Esophageal Dilation
    • Surgery
    • Stent placement
    • Laparoscopic Heller Myotomy
    • Medications
    • Lifestyle Changes

    • Europe Esophageal Dysphagia by Product

    • Feeding Tube
    • Nasogastric Tube
    • Percutaneous Endoscopic Gastrostomy
    • Nutritional Solutions
    • Thickeners
    • Beverages
    • Purees
    • Drugs
    • Proton Pump Inhibitors
    • Other

    • Europe Esophageal Dysphagia by End-User

    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Research Centers
        • Others

      • Germany Outlook (USD Billion, 2018-2032)

    • Germany Esophageal Dysphagia by Diagnosis

    • Dynamic Swallowing Study
    • X-ray
    • Endoscope
    • Manometry
    • Imaging scans
    • MRI scan
    • CT scan

    • Germany Esophageal Dysphagia by Treatment

    • Esophageal Dilation
    • Surgery
    • Stent placement
    • Laparoscopic Heller Myotomy
    • Medications
    • Lifestyle Changes

    • Germany Esophageal Dysphagia by Product

    • Feeding Tube
    • Nasogastric Tube
    • Percutaneous Endoscopic Gastrostomy
    • Nutritional Solutions
    • Thickeners
    • Beverages
    • Purees
    • Drugs
    • Proton Pump Inhibitors
    • Other

    • Germany Esophageal Dysphagia by End-User

    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Research Centers
        • Others

      • France Outlook (USD Billion, 2018-2032)

    • France Esophageal Dysphagia by Diagnosis

    • Dynamic Swallowing Study
    • X-ray
    • Endoscope
    • Manometry
    • Imaging scans
    • MRI scan
    • CT scan

    • France Esophageal Dysphagia by Treatment

    • Esophageal Dilation
    • Surgery
    • Stent placement
    • Laparoscopic Heller Myotomy
    • Medications
    • Lifestyle Changes

    • France Esophageal Dysphagia by Product

    • Feeding Tube
    • Nasogastric Tube
    • Percutaneous Endoscopic Gastrostomy
    • Nutritional Solutions
    • Thickeners
    • Beverages
    • Purees
    • Drugs
    • Proton Pump Inhibitors
    • Other

    • France Esophageal Dysphagia by End-User

    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Research Centers
        • Others

      • UK Outlook (USD Billion, 2018-2032)

    • UK Esophageal Dysphagia by Diagnosis

    • Dynamic Swallowing Study
    • X-ray
    • Endoscope
    • Manometry
    • Imaging scans
    • MRI scan
    • CT scan

    • UK Esophageal Dysphagia by Treatment

    • Esophageal Dilation
    • Surgery
    • Stent placement
    • Laparoscopic Heller Myotomy
    • Medications
    • Lifestyle Changes

    • UK Esophageal Dysphagia by Product

    • Feeding Tube
    • Nasogastric Tube
    • Percutaneous Endoscopic Gastrostomy
    • Nutritional Solutions
    • Thickeners
    • Beverages
    • Purees
    • Drugs
    • Proton Pump Inhibitors
    • Other

    • UK Esophageal Dysphagia by End-User

    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Research Centers
        • Others

      • ITALY Outlook (USD Billion, 2018-2032)

    • ITALY Esophageal Dysphagia by Diagnosis

    • Dynamic Swallowing Study
    • X-ray
    • Endoscope
    • Manometry
    • Imaging scans
    • MRI scan
    • CT scan

    • ITALY Esophageal Dysphagia by Treatment

    • Esophageal Dilation
    • Surgery
    • Stent placement
    • Laparoscopic Heller Myotomy
    • Medications
    • Lifestyle Changes

    • ITALY Esophageal Dysphagia by Product

    • Feeding Tube
    • Nasogastric Tube
    • Percutaneous Endoscopic Gastrostomy
    • Nutritional Solutions
    • Thickeners
    • Beverages
    • Purees
    • Drugs
    • Proton Pump Inhibitors
    • Other

    • ITALY Esophageal Dysphagia by End-User

    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Research Centers
        • Others

      • SPAIN Outlook (USD Billion, 2018-2032)

    • SPAIN Esophageal Dysphagia by Diagnosis

    • Dynamic Swallowing Study
    • X-ray
    • Endoscope
    • Manometry
    • Imaging scans
    • MRI scan
    • CT scan

    • SPAIN Esophageal Dysphagia by Treatment

    • Esophageal Dilation
    • Surgery
    • Stent placement
    • Laparoscopic Heller Myotomy
    • Medications
    • Lifestyle Changes

    • SPAIN Esophageal Dysphagia by Product

    • Feeding Tube
    • Nasogastric Tube
    • Percutaneous Endoscopic Gastrostomy
    • Nutritional Solutions
    • Thickeners
    • Beverages
    • Purees
    • Drugs
    • Proton Pump Inhibitors
    • Other

    • SPAIN Esophageal Dysphagia by End-User

    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Research Centers
        • Others

      • Rest Of Europe Outlook (USD Billion, 2018-2032)

    • Rest Of Europe Esophageal Dysphagia by Diagnosis

    • Dynamic Swallowing Study
    • X-ray
    • Endoscope
    • Manometry
    • Imaging scans
    • MRI scan
    • CT scan

    • Rest Of Europe Esophageal Dysphagia by Treatment

    • Esophageal Dilation
    • Surgery
    • Stent placement
    • Laparoscopic Heller Myotomy
    • Medications
    • Lifestyle Changes

    • Rest Of Europe Esophageal Dysphagia by Product

    • Feeding Tube
    • Nasogastric Tube
    • Percutaneous Endoscopic Gastrostomy
    • Nutritional Solutions
    • Thickeners
    • Beverages
    • Purees
    • Drugs
    • Proton Pump Inhibitors
    • Other

    • Rest Of Europe Esophageal Dysphagia by End-User

    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Research Centers
        • Others

    • Asia-Pacific Outlook (USD Billion, 2018-2032)

    • Asia-Pacific Esophageal Dysphagia by Diagnosis

    • Dynamic Swallowing Study
    • X-ray
    • Endoscope
    • Manometry
    • Imaging scans
    • MRI scan
    • CT scan

    • Asia-Pacific Esophageal Dysphagia by Treatment

    • Esophageal Dilation
    • Surgery
    • Stent placement
    • Laparoscopic Heller Myotomy
    • Medications
    • Lifestyle Changes

    • Asia-Pacific Esophageal Dysphagia by Product

    • Feeding Tube
    • Nasogastric Tube
    • Percutaneous Endoscopic Gastrostomy
    • Nutritional Solutions
    • Thickeners
    • Beverages
    • Purees
    • Drugs
    • Proton Pump Inhibitors
    • Other

    • Asia-Pacific Esophageal Dysphagia by End-User

    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Research Centers
        • Others

      • China Outlook (USD Billion, 2018-2032)

    • China Esophageal Dysphagia by Diagnosis

    • Dynamic Swallowing Study
    • X-ray
    • Endoscope
    • Manometry
    • Imaging scans
    • MRI scan
    • CT scan

    • China Esophageal Dysphagia by Treatment

    • Esophageal Dilation
    • Surgery
    • Stent placement
    • Laparoscopic Heller Myotomy
    • Medications
    • Lifestyle Changes

    • China Esophageal Dysphagia by Product

    • Feeding Tube
    • Nasogastric Tube
    • Percutaneous Endoscopic Gastrostomy
    • Nutritional Solutions
    • Thickeners
    • Beverages
    • Purees
    • Drugs
    • Proton Pump Inhibitors
    • Other

    • China Esophageal Dysphagia by End-User

    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Research Centers
        • Others

      • Japan Outlook (USD Billion, 2018-2032)

    • Japan Esophageal Dysphagia by Diagnosis

    • Dynamic Swallowing Study
    • X-ray
    • Endoscope
    • Manometry
    • Imaging scans
    • MRI scan
    • CT scan

    • Japan Esophageal Dysphagia by Treatment

    • Esophageal Dilation
    • Surgery
    • Stent placement
    • Laparoscopic Heller Myotomy
    • Medications
    • Lifestyle Changes

    • Japan Esophageal Dysphagia by Product

    • Feeding Tube
    • Nasogastric Tube
    • Percutaneous Endoscopic Gastrostomy
    • Nutritional Solutions
    • Thickeners
    • Beverages
    • Purees
    • Drugs
    • Proton Pump Inhibitors
    • Other

    • Japan Esophageal Dysphagia by End-User

    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Research Centers
        • Others

      • India Outlook (USD Billion, 2018-2032)

    • India Esophageal Dysphagia by Diagnosis

    • Dynamic Swallowing Study
    • X-ray
    • Endoscope
    • Manometry
    • Imaging scans
    • MRI scan
    • CT scan

    • India Esophageal Dysphagia by Treatment

    • Esophageal Dilation
    • Surgery
    • Stent placement
    • Laparoscopic Heller Myotomy
    • Medications
    • Lifestyle Changes

    • India Esophageal Dysphagia by Product

    • Feeding Tube
    • Nasogastric Tube
    • Percutaneous Endoscopic Gastrostomy
    • Nutritional Solutions
    • Thickeners
    • Beverages
    • Purees
    • Drugs
    • Proton Pump Inhibitors
    • Other

    • India Esophageal Dysphagia by End-User

    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Research Centers
        • Others

      • Australia Outlook (USD Billion, 2018-2032)

    • Australia Esophageal Dysphagia by Diagnosis

    • Dynamic Swallowing Study
    • X-ray
    • Endoscope
    • Manometry
    • Imaging scans
    • MRI scan
    • CT scan

    • Australia Esophageal Dysphagia by Treatment

    • Esophageal Dilation
    • Surgery
    • Stent placement
    • Laparoscopic Heller Myotomy
    • Medications
    • Lifestyle Changes

    • Australia Esophageal Dysphagia by Product

    • Feeding Tube
    • Nasogastric Tube
    • Percutaneous Endoscopic Gastrostomy
    • Nutritional Solutions
    • Thickeners
    • Beverages
    • Purees
    • Drugs
    • Proton Pump Inhibitors
    • Other

    • Australia Esophageal Dysphagia by End-User

    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Research Centers
        • Others

      • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)

    • Rest of Asia-Pacific Esophageal Dysphagia by Diagnosis

    • Dynamic Swallowing Study
    • X-ray
    • Endoscope
    • Manometry
    • Imaging scans
    • MRI scan
    • CT scan

    • Rest of Asia-Pacific Esophageal Dysphagia by Treatment

    • Esophageal Dilation
    • Surgery
    • Stent placement
    • Laparoscopic Heller Myotomy
    • Medications
    • Lifestyle Changes

    • Rest of Asia-Pacific Esophageal Dysphagia by Product

    • Feeding Tube
    • Nasogastric Tube
    • Percutaneous Endoscopic Gastrostomy
    • Nutritional Solutions
    • Thickeners
    • Beverages
    • Purees
    • Drugs
    • Proton Pump Inhibitors
    • Other

    • Rest of Asia-Pacific Esophageal Dysphagia by End-User

    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Research Centers
        • Others

    • Rest of the World Outlook (USD Billion, 2018-2032)

    • Rest of the World Esophageal Dysphagia by Diagnosis

    • Dynamic Swallowing Study
    • X-ray
    • Endoscope
    • Manometry
    • Imaging scans
    • MRI scan
    • CT scan

    • Rest of the World Esophageal Dysphagia by Treatment

    • Esophageal Dilation
    • Surgery
    • Stent placement
    • Laparoscopic Heller Myotomy
    • Medications
    • Lifestyle Changes

    • Rest of the World Esophageal Dysphagia by Product

    • Feeding Tube
    • Nasogastric Tube
    • Percutaneous Endoscopic Gastrostomy
    • Nutritional Solutions
    • Thickeners
    • Beverages
    • Purees
    • Drugs
    • Proton Pump Inhibitors
    • Other

    • Rest of the World Esophageal Dysphagia by End-User

    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Research Centers
        • Others

      • Middle East Outlook (USD Billion, 2018-2032)

    • Middle East Esophageal Dysphagia by Diagnosis

    • Dynamic Swallowing Study
    • X-ray
    • Endoscope
    • Manometry
    • Imaging scans
    • MRI scan
    • CT scan

    • Middle East Esophageal Dysphagia by Treatment

    • Esophageal Dilation
    • Surgery
    • Stent placement
    • Laparoscopic Heller Myotomy
    • Medications
    • Lifestyle Changes

    • Middle East Esophageal Dysphagia by Product

    • Feeding Tube
    • Nasogastric Tube
    • Percutaneous Endoscopic Gastrostomy
    • Nutritional Solutions
    • Thickeners
    • Beverages
    • Purees
    • Drugs
    • Proton Pump Inhibitors
    • Other

    • Middle East Esophageal Dysphagia by End-User

    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Research Centers
        • Others

      • Africa Outlook (USD Billion, 2018-2032)

    • Africa Esophageal Dysphagia by Diagnosis

    • Dynamic Swallowing Study
    • X-ray
    • Endoscope
    • Manometry
    • Imaging scans
    • MRI scan
    • CT scan

    • Africa Esophageal Dysphagia by Treatment

    • Esophageal Dilation
    • Surgery
    • Stent placement
    • Laparoscopic Heller Myotomy
    • Medications
    • Lifestyle Changes

    • Africa Esophageal Dysphagia by Product

    • Feeding Tube
    • Nasogastric Tube
    • Percutaneous Endoscopic Gastrostomy
    • Nutritional Solutions
    • Thickeners
    • Beverages
    • Purees
    • Drugs
    • Proton Pump Inhibitors
    • Other

    • Africa Esophageal Dysphagia by End-User

    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Research Centers
        • Others

      • Latin America Outlook (USD Billion, 2018-2032)

    • Latin America Esophageal Dysphagia by Diagnosis

    • Dynamic Swallowing Study
    • X-ray
    • Endoscope
    • Manometry
    • Imaging scans
    • MRI scan
    • CT scan

    • Latin America Esophageal Dysphagia by Treatment

    • Esophageal Dilation
    • Surgery
    • Stent placement
    • Laparoscopic Heller Myotomy
    • Medications
    • Lifestyle Changes

    • Latin America Esophageal Dysphagia by Product

    • Feeding Tube
    • Nasogastric Tube
    • Percutaneous Endoscopic Gastrostomy
    • Nutritional Solutions
    • Thickeners
    • Beverages
    • Purees
    • Drugs
    • Proton Pump Inhibitors
    • Other

    • Latin America Esophageal Dysphagia by End-User

    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Research Centers
        • Others
    Esophageal Dysphagia Market Research Report – Forecast to 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027